Argentina Pharmaceuticals & Healthcare Q4 2018
In Latin America, Argentina will continue to be one of the attractive markets for drugmakers. The shift in the country’sdemographics towards an ageing population and an increasing burden of chronic diseases will boost demand for medicines.Combined with increasing healthcare expenditure and the successful implementation of healthcare reforms, will bolster country'sattractiveness in the long term. However, in the short term, weak intellectual property environment and the currently limited accessto healthcare services for a significant proportion of the population will continue to act as barriers to drugmaker investment.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook